Donate

Latest news & articles

Latest news
Type 1 diabetes research breakthrough shows insulin-producing cells can be regenerated
Research

Type 1 diabetes research breakthrough shows insulin-producing cells can be regenerated

We could be one step closer to replacing the need for regular insulin injections in people living with type 1 diabetes (T1D), thanks to JDRF-funded Australian research that was published this week in the prestigious Nature journal. Why is this research important? During T1D development, the immune system mistakenly attacks the insulin-producing beta cells in […]
World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed
Research

World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed

  A JDRF-funded, world-first clinical trial has shown that a commonly prescribed rheumatoid arthritis drug (baricitinib) can preserve the body’s own insulin production and suppress the progression of type 1 diabetes (T1D) in those newly diagnosed with the condition. This comes after three decades of research out of the St Vincent’s Institute (SVI) in Melbourne, […]
New clinical trial looking for newly diagnosed children and young adults with T1D
Research

New clinical trial looking for newly diagnosed children and young adults with T1D

In people newly diagnosed with type 1 diabetes (T1D) there is often a ‘honeymoon’ phase where some pancreatic beta cells are still able to produce insulin. Committed to improving the lives of those with T1D, JDRF has invested in several clinical studies under the Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC),  investigating whether we can […]
The Research Pathway: Turning an Idea Into a T1D Breakthrough
Research

The Research Pathway: Turning an Idea Into a T1D Breakthrough

You may have heard that getting a new T1D treatment or device to market can take around 12 to 15 years. This is because there’s a huge amount of work that must take place before that intervention can be approved as being safe for use – from laboratory research in cells, right through to large […]
JDRF Announces Australia’s First Population Screening Study for T1D
Research

JDRF Announces Australia’s First Population Screening Study for T1D

In a huge step forward for research into the prevention of T1D, JDRF yesterday announced that Dr Kirstine Bell will lead a pilot study to screen children for early signs of T1D. This study will be the first in Australia – and one of only three in the world – to screen people from the […]
JDRF welcomes commitment to continue work of Clinical Research Network by the Coalition Government
Research

JDRF welcomes commitment to continue work of Clinical Research Network by the Coalition Government

Funding will help support translate more innovations into useful treatments for people living with type 1 diabetes. JDRF welcomes the news today that the Liberal National Government has committed to continued support of the Type 1 Diabetes Clinical Research Network (CRN).  The $54.5m over five years, will continue the work of the network, most recently supported by […]